Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes

This study has been completed.
Information provided by:
Bristol-Myers Squibb Identifier:
First received: July 26, 2007
Last updated: March 13, 2009
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)